Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
Ticker Information
Ticker
TRDACompany Name
ENTRADA THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQENTRADA THERAPEUTICS INC - Price to Free Cash Flow Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
TRDA - P/FCF Historical data
| Date | Free Cash Flow | Market Capitalization | Price to Free Cash Flow |
|---|---|---|---|
| 6/30/2025 | $ -126.56M | $ 226.32M | 0 |
| 3/31/2025 | $ -58.01M | $ 327.16M | 0 |
| 12/31/2024 | $ -44.72M | $ 450.38M | 0 |
| 9/30/2024 | $ -17.46M | $ 696.76M | 0 |
| 6/30/2024 | $ -18.5M | $ 588.12M | 0 |
| 3/31/2024 | $ -93.9M | $ 468.57M | 0 |
| 12/31/2023 | $ 134.19M | $ 427.07M | 3.18 |
| 9/30/2023 | $ 111.17M | $ 566.92M | 5.1 |
| 6/30/2023 | $ 108.81M | $ 512.38M | 4.71 |
| 3/31/2023 | $ 126.64M | $ 396.04M | 3.13 |
Key Performance Insights, Last 5 Years
- ENTRADA THERAPEUTICS INC's latest trailing twelve months (TTM) P/FCF stands at 0.
- Over the past 5 years, ENTRADA THERAPEUTICS INC's average P/FCF has been 4.03.
- The median P/FCF for ENTRADA THERAPEUTICS INC during this period was 3.95
- ENTRADA THERAPEUTICS INC reached its highest P/FCF over the past 5 years at 5.1.
- The lowest P/FCF recorded by ENTRADA THERAPEUTICS INC in the same timeframe 3.13
ENTRADA THERAPEUTICS INC's P/FCF vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
P/FCF Benchmarks
Similar metrics to P/FCF:
- Free Cash Flow Yield - [Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Price to Sales - [Calculation] Measures a company’s [MarketCap] in relation to its [Revenue].
- Enterprise Value over Free Cash Flow - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its Free Cash Flow [FCF].
- Free Cash Flow - [Calculation] Free Cash Flow is a metric that measures the cash that remains after a company pays its operating expenses [OpEx] and capital expenditures [CapEx]. It can be calculated as Net Cash Flow from Operations [NCFO] minus capital expenditures.
Definition of Price to Free Cash Flow
[Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].Market Cap / FCF
(=) P/FCF P/FCF for ENTRADA THERAPEUTICS INC is calculated as follows: Market Cap [ $ 0 ] / FCF [ $ -27.89M ]
(=) P/FCF [ 0 ] TRDA - Price to Free Cash Flow, Last 5 years
3.13
Minimum
Mar 31, 2023
5.1
Maximum
Sep 30, 2023
4.03
Average
3.95
Median
P/FCF Benchmark AnalysisMarket
The chart above depicts the distribution of P/FCF for companies in the Total Stock Market. The average P/FCF of the companies is 18.31 with a standard deviation of 12.92.
The following table provides additional summary stats:
P/FCF in the Market:
| filtered constituents | 2.23K |
|---|---|
| min | 0.06 |
| max | 60.45 |
| average | 18.31 |
| median | 14.73 |
| std | 12.92 |